CRSP filings
Corporate insider profile
Samarth Kulkarni Filing Activity
Latest reported as Chief Executive Officer of CRISPR Therapeutics AG (CRSP).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$2,583,193.34
- Latest transaction
- Oct 19, 2026
Affiliated corporations
Reported company relationships
Transaction history
